Affymetrix (Santa Clara, California) And Leica Microsystems Announce The Launch Of Fully Automated RNA In Situ Hybridization Assays

SANTA CLARA, Calif.--(BUSINESS WIRE)--Affymetrix, Inc. (NASDAQ:AFFX) and Leica Biosystems announce the launch of Affymetrix’ fully automated RNA in situ hybridization assays ViewRNATM eZ Assays on the Leica BOND RX staining platform. These assays detect coding RNA as well as novel non-coding markers in formalin-fixed paraffin-embedded (FFPE) tissues. Dedicated for research use only*, the assays provide researchers with a powerful automated solution for drug discovery, translational research, and the development of new diagnostic tests for personalized medicine. The automation significantly reduces hands-on time and assay run time for profiling single-cell gene expression.

Help employers find you! Check out all the jobs and post your resume.